阿替唑单抗
转移性尿路上皮癌
尿路上皮癌
肿瘤科
医学
尿路上皮癌
内科学
泌尿科
相(物质)
膀胱癌
癌症
化学
免疫疗法
无容量
有机化学
作者
J. E. Rosenberg,M.D. Galsky,Thomas Powles,Daniel P. Petrylak,Joaquim Bellmunt,Y. Loriot,A. Necchi,Jean Hoffman‐Censits,José Luis Perez‐Gracia,Michiel S. van der Heijden,Robert Dreicer,Ignacio Durán,D Castellano,Alexandra Drakaki,Margitta Retz,Srikala S. Sridhar,P. Grivas,Evan Y. Yu,Peter H. O’Donnell,H.A. Burris
出处
期刊:ESMO open
[Elsevier BV]
日期:2024-12-01
卷期号:9 (12): 103972-103972
被引量:17
标识
DOI:10.1016/j.esmoop.2024.103972
摘要
With long-term follow-up, atezolizumab monotherapy demonstrated clinically meaningful efficacy with durable responses in a subset of patients with metastatic UC; there were no new safety signals.
科研通智能强力驱动
Strongly Powered by AbleSci AI